Purchase Order 15B51926P00000060
- Not listed
- McKesson Corporation was awarded a Firm Fixed Price Purchase Order (OPEN MKT PO 3709) by the Federal Correctional Complex Pollock, a civilian facility under the Bureau of Prisons, with a ceiling value of $1,330.30. The award, issued on September 30, 2026, with an ultimate completion date of the same day, represents a direct procurement with no set-aside designation. Performance is scheduled to occur in Irving, Texas, McKesson's headquarters location, where the company maintains significant...
- McKesson Corporation was awarded a Firm Fixed Price Purchase Order valued at $1,141.65 by the Federal Correctional Complex Pollock, a civilian agency within the Bureau of Prisons, with an ultimate completion date of September 30, 2026. The award was made on September 30, 2026, with no set-aside designation applied. The place of performance is Irving, Texas, McKesson's headquarters location. This purchase order represents a continuation of McKesson's extensive engagement with the Bureau of...
- McKesson Corporation was awarded a firm fixed price purchase order valued at $3,034.19 by the Federal Correctional Complex Pollock, a civilian agency within the Bureau of Prisons. The award, announced on November 19, 2025, with an ultimate completion date of November 20, 2025, represents an open market procurement with no set-aside designation. Performance of this contract will take place in Irving, Texas, where McKesson maintains its corporate headquarters. As a large healthcare services and...
- McKesson Corporation was awarded a December monthly delivery order by the Federal Correctional Complex Pollock, a civilian agency under the Department of Justice's Bureau of Prisons, with a ceiling value of $500,000 and a firm fixed price structure. The order, dated December 31, 2025, with an ultimate completion date of December 31, 2025, is to be performed in Irving, Texas. This delivery order represents a continuation of McKesson's ongoing role as a critical pharmaceutical and medical supply...
- McKesson Corporation, doing business as McKesson, has been awarded a purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock (DOJ-BOP) to provide pharmaceuticals. With a value of approximately $1,663, this firm fixed price contract runs from August 16, 2023 through August 31, 2023 and will deliver medications to support DOJ-BOP operations at its facility located in Irving, Texas. McKesson will perform as the prime contractor, with no major...
- McKesson Corporation, doing business as McKesson, has been awarded a $40,000 purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock to provide pharmaceuticals. The firm fixed price contract runs from November 1, 2023 through November 30, 2023 and will be performed by McKesson in Irving, Texas. McKesson will deliver pharmaceutical products to support medical care operations at the Bureau of Prisons facility. No subcontractors or set aside designations...
- Mckesson Corporation, doing business as Mckesson, has been awarded a $1,417.80 firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock (DOJ-BOP) to provide pharmaceuticals. Performance will take place in Irving, Texas under a two-week period starting August 16th and concluding August 31st, 2023. No additional details were provided on the original solicitation or products/services requested. The award is not associated with a larger...
- Mckesson Corporation, doing business as Mckesson, has been awarded a $16,330 purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock to provide pharmaceuticals. The firm fixed price contract runs from November 1, 2023 through November 30, 2023 and will be performed by Mckesson in Irving, Texas. No subcontractors or set aside designations were specified. The DOJ Bureau of Prisons oversees the medical care of federal inmates, so this award will deliver...
- Mckesson Corporation, doing business as Mckesson, has been awarded a $1,694.82 firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock (DOJ-BOP) to provide pharmaceuticals. The contract has a period of performance from September 7, 2023 through September 30, 2023, with all work to be conducted by Mckesson at its facility located in Irving, Texas. No major subcontractors or set aside designations were identified. The DOJ-BOP oversees the...
- McKesson Corporation, doing business as McKesson, has been awarded a firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Correctional Complex Pollock (DOJ-BOP) to provide pharmaceuticals. Valued at approximately $1,104, the contract has a period of performance from June 22, 2023 through June 30, 2023 for delivery to an address in Irving, Texas. As one of the largest pharmaceutical distributors in the United States, McKesson will leverage its extensive...
McKesson Corporation was awarded a firm fixed price purchase order valued at $6,832.84 by the Federal Correctional Complex Pollock, a civilian facility under the Department of Justice's Bureau of Prisons. The award, designated as Controlled Subs PO 3725, was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. Performance will be executed in Irving, Texas, where McKesson maintains its corporate headquarters. This contract represents a non-competed purchase order with no set-aside designation and reflects McKesson's established role as a primary pharmaceutical and medical supply provider to the Bureau of Prisons. This award falls within McKesson's broader federal contracting relationship with correctional facilities, where the company consistently delivers controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals. As a large business contractor with significant federal contract vehicles including a $25.5 million Blanket Purchase Agreement with the Department of Homeland Security's Customs and Border Protection, McKesson has demonstrated sustained capability in supporting federal healthcare infrastructure and pharmaceutical distribution requirements across multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/9/25 |